Navigation Links
Sanofi-aventis U.S. Introduces BenzaClin(R) Carekit

BRIDGEWATER, N.J., Aug. 4 /PRNewswire-FirstCall/ -- With acne being one of the most common skin diseases affecting nearly 80 percent of people between the ages of 12 and 24, Dermik Laboratories, a business of sanofi-aventis U.S., announced today the availability of the BenzaClin(R) (clindamycin 1%-benzoyl peroxide 5% gel) carekit, a unique prescribing option for patients with acne who want to add a moisturizing agent to their skin care regimen.

The BenzaClin carekit features the 50g BenzaClin(R) PUMP packaged with 20 ampoules of Viscontour(R) Serum, a cosmetic product. Viscontour Serum topical hyaluronic acid offers a simple and convenient way of moisturizing the skin. When applied topically Viscontour acts as a natural moisture reservoir for the skin.

"We are excited about the availability of the BenzaClin carekit because it broadens the landscape of what physicians can offer their patients who are seeking a moisturizing agent while using BenzaClin for their acne," says Brent Ragans, Vice President and Head of the General Therapeutics Business Unit, sanofi-aventis.

While maintaining moisture can be a challenge for teens and young adults dealing with acne, the arrival of the carekit offers an acne treatment and a moisturizer under one easy to write prescription.

In addition to the BenzaClin carekit, patients can choose from a variety of prescribing options including the one-of-a-kind BenzaClin 50g PUMP, which is the flagship of the BenzaClin line of products, as well as the BenzaClin(R) 25g jar.

BenzaClin is a topical, prescription acne treatment that combines the acne-fighting power of benzoyl peroxide and clindamycin, and has been shown to reduce acne in as little as two weeks. For more information about the BenzaClin carekit and the BenzaClin prescribing family, visit or for more information about acne please visit .

About BenzaClin(R)

BenzaClin(R) is proven effective in treating acne, including whiteheads, blackheads, and pimples. In clinical trials, BenzaClin(R) worked better than either individual components, clindamycin or benzoyl peroxide alone for the topical treatment of acne. With BenzaClin(R), improvements have been shown to occur in as early as two weeks.

BenzaClin(R) is indicated for the topical treatment of acne.

Important Safety Information

BenzaClin(R) was studied in mild to moderate acne patients. BenzaClin(R) is an acne product you can get with a doctor's prescription. Side effects are usually limited to the skin and include dry skin, itching, peeling, redness and sunburn. Also, clindamycin, an ingredient in BenzaClin(R), may cause diarrhea. If you experience severe diarrhea, stop using BenzaClin(R) and call your doctor immediately. You should not use BenzaClin(R) if you are allergic to clindamycin, benzoyl peroxide, or the antibiotic lincomycin, or if you have a history of colitis.

Please see full prescribing information at

About Viscontour(R)

Viscontour(R) Serum is a cosmetic hydration agent that offers you a simple and convenient way of moisturizing your skin. Applied topically, Viscontour(R) Serum works to help restore and sustain hydration.

About sanofi-aventis

Sanofi-aventis U.S. is an affiliate of sanofi-aventis, a leading global pharmaceutical company that discovers, develops and distributes therapeutic solutions to help improve the lives of patients. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY). For more information, or

    Amy Ba
    Tel: 908-981-6563
    Mobile: 646-207-4935

SOURCE sanofi-aventis
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Sanofi-aventis Announces Settlement of Average Wholesale Price Civil Suits With the U.S. Department of Justice Relating to Anzemet(R)
2. Shareholder Class Action Filed Against Sanofi-Aventis by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
3. Sanofi-aventis SoloSTAR(R) Insulin Pen for Lantus and Apidra Receives the Prestigious GOOD DESIGN Award
4. ThalesNano Inc. and sanofi-aventis R&D Collaborate on Continuous Process Chemistry in Order to Dramatically Reduce Drug Realization Time
5. RainDance Technologies Signs a Collaboration Agreement with sanofi-aventis and Louis Pasteur University to Launch dScreen Consortium within ALSACE BIOVALLEY cluster
6. AEterna Zentaris and Sanofi-Aventis Sign a Development, Commercialization and Licensing Agreement for Cetrorelix in Benign Prostatic Hyperplasia
7. BioWa Announces License of POTELLIGENT(R) Technology to sanofi-aventis
8. Sanofi-aventis U.S. to Acquire Oral Chronic Lymphocytic Leukemia Treatment
9. Sanofi-aventis U.S. Announces Settlement of Medicaid Best Price Investigation
10. Sanofi-aventis Announces Second Quarter 2009 Results
11. SAFC Expands Hi-Potency API Manufacturing and Introduces Solid-Form Testing at Its Madison Facility
Post Your Comments:
(Date:11/24/2015)... PHILADELPIA, PA (PRWEB) , ... November 24, 2015 , ... ... young entrepreneurs at competitive events in five states to develop and pitch their BIG ... student projects from each state are competing for votes to win the title of ...
(Date:11/24/2015)... , November 24, 2015 SHPG ) ... participate in the Piper Jaffray 27 th Annual Healthcare Conference ... December 1, 2015, at 8:30 a.m. EST (1:30 p.m. GMT). ... Chief Financial Officer, will participate in the Piper Jaffray 27 th ... , NY on Tuesday, December 1, 2015, at 8:30 a.m. EST ...
(Date:11/24/2015)... , Nov. 24, 2015  Tikcro Technologies Ltd. (OTCQB: TIKRF) today announced ... 29, 2015 at 11:00 a.m. Israel time, at ... 98 Yigal Allon Street, 36 th Floor, Tel Aviv, ... Eric Paneth and Izhak Tamir to the Board of ... as external directors; , approval of an amendment to certain terms ...
(Date:11/24/2015)... SAN FRANCISCO , Nov. 24, 2015 /PRNewswire/ ... today announced that Emily Leproust, Ph.D., Twist Bioscience ... Piper Jaffray Healthcare Conference on December 1, 2015 ... Palace Hotel in New York City. ... . Twist Bioscience is on ...
Breaking Biology Technology:
(Date:11/17/2015)... -- Vigilant Solutions announces today that Mr. Dick W. ... --> --> Mr. Boyce ... at TPG Capital, one of the largest global investment ... revenue.  He founded and led TPG,s Operating Group, which ... 1997 to 2013.  In his first role, he served ...
(Date:11/16/2015)... Calif. , Nov 16, 2015  Synaptics ... of human interface solutions, today announced expansion of ... TouchView ™ touch controller and display driver ... revolution of smartphones. These new TDDI products add ... TD4100 (HD resolution), TD4302 (WQHD resolution), and TD4322 ...
(Date:11/12/2015)... 12, 2015  Arxspan has entered into an ... Harvard for use of its ArxLab cloud-based suite ... The partnership will support the institute,s efforts to ... research information internally and with external collaborators. The ... managing the Institute,s electronic laboratory notebook, compound and ...
Breaking Biology News(10 mins):